Pages 176 Published DateApril 2018 PRICE $4700 Editor's Ratings 4 based on 137 customer reviews ★★★★★ Cancer Tubulin Inhibitors Market By Product ( Docetaxel, Trastuzumab Emtansine, Abraxane, Brentuximab Vedotin, Cabazitaxel ), By Application ( Non-Small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Ovarian Cancer ), Industry Trends, Estimation & Forecast, 2017 - 2025 Buy Now Request for Sample